Single Application of Low-Dose, Hydroxyapatite-Bound BMP-2 or GDF-5 Induces Long-Term Bone Formation and Biomechanical Stabilization of a Bone Defect in a Senile Sheep Lumbar Osteopenia Model.
Single Application of Low-Dose, Hydroxyapatite-Bound BMP-2 or GDF-5 Induces Long-Term Bone Formation and Biomechanical Stabilization of a Bone Defect in a Senile Sheep Lumbar Osteopenia Model.
复制标题
DOI:
10.3390/biomedicines10020513
复制
发表时间:
2022-02-21
期刊:
影响因子:
4.7
通讯作者:
Kinne RW
中科院分区:
文献类型:
--
作者:
Hasenbein I;Sachse A;Hortschansky P;Schmuck KD;Horbert V;Anders C;Lehmann T;Huber R;Maslaris A;Layher F;Braun C;Roth A;Plöger F;Kinne RW
Effects of hydroxyapatite (HA) particles with bone morphogenetic BMP-2 or GDF-5 were compared in sheep lumbar osteopenia; in vitro release in phosphate-buffered saline (PBS) or sheep serum was assessed by ELISA. Lumbar (L) vertebral bone defects (Ø 3.5 mm) were generated in aged, osteopenic female sheep (n = 72; 9.00 ± 0.11 years; mean ± SEM). Treatment was: (a) HA particles (2.5 mg; L5); or (b) particles coated with BMP-2 (1 µg; 10 µg) or GDF-5 (5 µg; 50 µg; L4; all groups n = 6). Untouched vertebrae (L3) served as controls. Three and nine months post-therapy, bone formation was assessed by osteodensitometry, histomorphometry, and biomechanical testing. Cumulative 14-day BMP release was high in serum (76–100%), but max. 1.4% in PBS. In vivo induction of bone formation by HA particles with either growth factor was shown by: (i) significantly increased bone volume, trabecular and cortical thickness (overall increase HA + BMP vs. control close to the injection channel 71%, 110%, and 37%, respectively); (ii) partial significant effects for bone mineral density, bone formation, and compressive strength (increase 17%; 9 months; GDF-5). Treatment effects were not dose-dependent. Combined HA and BMPs (single low-dose) highly augment long-term bone formation and biomechanical stabilization in sheep lumbar osteopenia. Thus, carrier-bound BMP doses 20,000-fold to 1000-fold lower than previously applied appear suitable for spinal fusion/bone regeneration and improved treatment safety.
登录
查看更多内容
影响因子:
1.8
作者:
Depprich, R.;Handschel, J.;Wuerzler, K. K.
通讯作者:
Wuerzler, K. K.
影响因子:
--
作者:
Eschler A;Roepenack P;Roesner J;Herlyn PK;Martin H;Reichel M;Rotter R;Vollmar B;Mittlmeier T;Gradl G
通讯作者:
Gradl G
影响因子:
7.5
作者:
Chen S;Jia L;Zhang S;Zheng Y;Zhou Y
通讯作者:
Zhou Y
影响因子:
1.5
作者:
Akiyama, H;Shukunami, C;Hiraki, Y
通讯作者:
Hiraki, Y
影响因子:
19.6
作者:
Ducy, P;Karsenty, G
通讯作者:
Karsenty, G